FHTX
Price
$4.83
Change
-$0.09 (-1.83%)
Updated
Sep 8 closing price
Capitalization
286.83M
63 days until earnings call
Intraday BUY SELL Signals
NBP
Price
$1.78
Change
-$0.02 (-1.11%)
Updated
Sep 8 closing price
Capitalization
207.01M
65 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FHTX vs NBP

FHTX vs NBP Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
FHTX vs. NBP commentary
Sep 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHTX is a Hold and NBP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2026
Stock price -- (FHTX: $4.83 vs. NBP: $1.78)
Brand notoriety: FHTX and NBP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FHTX: 46% vs. NBP: 41%
Market capitalization -- FHTX: $286.83M vs. NBP: $207.01M
FHTX [@Biotechnology] is valued at $286.83M. NBP’s [@Biotechnology] market capitalization is $207.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $134.06B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FHTX’s FA Score shows that 0 FA rating(s) are green whileNBP’s FA Score has 0 green FA rating(s).

  • FHTX’s FA Score: 0 green, 5 red.
  • NBP’s FA Score: 0 green, 5 red.
According to our system of comparison, FHTX is a better buy in the long-term than NBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FHTX’s TA Score shows that 6 TA indicator(s) are bullish while NBP’s TA Score has 5 bullish TA indicator(s).

  • FHTX’s TA Score: 6 bullish, 4 bearish.
  • NBP’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, FHTX is a better buy in the short-term than NBP.

Price Growth

FHTX (@Biotechnology) experienced а -15.11% price change this week, while NBP (@Biotechnology) price change was +2.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.20%. For the same industry, the average monthly price growth was +1.71%, and the average quarterly price growth was +2584.47%.

Reported Earning Dates

FHTX is expected to report earnings on Nov 10, 2026.

NBP is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Biotechnology (-0.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FHTX($287M) has a higher market cap than NBP($207M). FHTX YTD gains are higher at: -8.889 vs. NBP (-55.276). FHTX has higher annual earnings (EBITDA): -66.35M vs. NBP (-121.6M). NBP has more cash in the bank: 191M vs. FHTX (168M). NBP has less debt than FHTX: NBP (4.46M) vs FHTX (43.1M). FHTX has higher revenues than NBP: FHTX (36.7M) vs NBP (0).
FHTXNBPFHTX / NBP
Capitalization287M207M139%
EBITDA-66.35M-121.6M55%
Gain YTD-8.889-55.27616%
P/E RatioN/AN/A-
Revenue36.7M0-
Total Cash168M191M88%
Total Debt43.1M4.46M967%
FUNDAMENTALS RATINGS
FHTX vs NBP: Fundamental Ratings
FHTX
NBP
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
83
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
5063
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NBP's Valuation (83) in the null industry is in the same range as FHTX (97). This means that NBP’s stock grew similarly to FHTX’s over the last 12 months.

NBP's Profit vs Risk Rating (100) in the null industry is in the same range as FHTX (100). This means that NBP’s stock grew similarly to FHTX’s over the last 12 months.

NBP's SMR Rating (97) in the null industry is in the same range as FHTX (100). This means that NBP’s stock grew similarly to FHTX’s over the last 12 months.

FHTX's Price Growth Rating (50) in the null industry is in the same range as NBP (63). This means that FHTX’s stock grew similarly to NBP’s over the last 12 months.

NBP's P/E Growth Rating (98) in the null industry is in the same range as FHTX (100). This means that NBP’s stock grew similarly to FHTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FHTXNBP
RSI
ODDS (%)
Bullish Trend 5 days ago
88%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 5 days ago
87%
Momentum
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
88%
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
75%
Advances
ODDS (%)
Bullish Trend 22 days ago
86%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
77%
Aroon
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 5 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
FHTX
Daily Signal:
Gain/Loss:
NBP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DHSIX32.070.21
+0.66%
Diamond Hill Small Cap I
GCSLX26.30-0.05
-0.19%
Victory Pioneer Global Equity C
FCAEX16.97-0.05
-0.29%
Fidelity Climate Action
RTLCX97.95-0.30
-0.31%
Russell Inv Tax-Managed US Large Cap C
ACUIX45.26-0.19
-0.42%
Columbia Dividend Opportunity C

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with ARVN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then ARVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
+1.03%
ARVN - FHTX
42%
Loosely correlated
+0.86%
EDIT - FHTX
41%
Loosely correlated
+4.87%
NKTX - FHTX
41%
Loosely correlated
+4.66%
DNLI - FHTX
41%
Loosely correlated
-2.28%
LCTX - FHTX
40%
Loosely correlated
-1.82%
More

NBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NBP has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NBP jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBP
1D Price
Change %
NBP100%
-1.11%
VCYT - NBP
43%
Loosely correlated
-0.19%
INDP - NBP
39%
Loosely correlated
+51.64%
SLS - NBP
33%
Poorly correlated
+0.72%
VSTM - NBP
32%
Poorly correlated
-1.46%
FHTX - NBP
32%
Poorly correlated
-1.83%
More